-
1
-
-
0026607973
-
Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease
-
DELMEZ JA, SLATOPOLSKY E: Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 19:303-317, 1992
-
(1992)
Am J Kidney Dis
, vol.19
, pp. 303-317
-
-
Delmez, J.A.1
Slatopolsky, E.2
-
2
-
-
0019976628
-
Minerals, vitamin D and parathyroid hormone in continuous ambulatory peritoneal dialysis
-
DELMEZ JA, SLATOPOLSKY E, MARTIN KJ, GEARING BN, HARTER HR: Minerals, vitamin D and parathyroid hormone in continuous ambulatory peritoneal dialysis. Kidney Int 21:862-867, 1982
-
(1982)
Kidney Int
, vol.21
, pp. 862-867
-
-
Delmez, J.A.1
Slatopolsky, E.2
Martin, K.J.3
Gearing, B.N.4
Harter, H.R.5
-
3
-
-
0026040622
-
Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate
-
HOU SH, ZHAO J, ELLMAN CF, HU J, GRIFFIN Z, SPIEGEL DM, BOURDEAU JE: Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis 18:217-224, 1991
-
(1991)
Am J Kidney Dis
, vol.18
, pp. 217-224
-
-
Hou, S.H.1
Zhao, J.2
Ellman, C.F.3
Hu, J.4
Griffin, Z.5
Spiegel, D.M.6
Bourdeau, J.E.7
-
4
-
-
0017876992
-
Aluminum toxicity during regular hacmodialysis
-
ELLIOTT HL, DRYBURGH F, FELL GS, SABET S, MACDOUGALL AI: Aluminum toxicity during regular hacmodialysis. Br Med J 1978:1101-1103, 1978
-
(1978)
Br Med J
, vol.1978
, pp. 1101-1103
-
-
Elliott, H.L.1
Dryburgh, F.2
Fell, G.S.3
Sabet, S.4
Macdougall, A.I.5
-
5
-
-
0018754598
-
Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey
-
PARKINSON IS, WARD MK, FEEST TD, FAWCETT RWP, KERR DNS: Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1:406-409, 1979
-
(1979)
Lancet
, vol.1
, pp. 406-409
-
-
Parkinson, I.S.1
Ward, M.K.2
Feest, T.D.3
Fawcett, R.W.P.4
Kerr, D.N.S.5
-
6
-
-
0017650827
-
Comparison of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis
-
PLATTS MM, GOODE GC, HISLOP JS: Comparison of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J ii:657-660, 1977
-
(1977)
Br Med J
, vol.2
, pp. 657-660
-
-
Platts, M.M.1
Goode, G.C.2
Hislop, J.S.3
-
7
-
-
0013918210
-
The effect of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure
-
CLARKSON EM, MCDONALD SJ, DE WARDENER HE: The effect of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure. Clin Sci (Lond) 30:425-438, 1966
-
(1966)
Clin Sci (Lond)
, vol.30
, pp. 425-438
-
-
Clarkson, E.M.1
Mcdonald, S.J.2
De Wardener, H.E.3
-
8
-
-
0026558214
-
Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients
-
PEI Y, HERCZ G, GREENWOOD C, SHERRARD D, SEGRE G, MANUEL A, SAIPHOO C, FENTON S: Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients. Kidney Int 41:1374-1382, 1992
-
(1992)
Kidney Int
, vol.41
, pp. 1374-1382
-
-
Pei, Y.1
Hercz, G.2
Greenwood, C.3
Sherrard, D.4
Segre, G.5
Manuel, A.6
Saiphoo, C.7
Fenton, S.8
-
9
-
-
0025224043
-
Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy
-
MERIC F, YAP P, BIA MJ: Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy. Am J Kidney Dis 16:459-464, 1990
-
(1990)
Am J Kidney Dis
, vol.16
, pp. 459-464
-
-
Meric, F.1
Yap, P.2
Bia, M.J.3
-
10
-
-
0024437788
-
Long term effects of calcium carbonate and 2.5 mEq/L calcium dialysate on mineral metabolism
-
SLATOPOLSKY E, WEERTS C, NORWOOD K, GILES K, FRYER P, FINCH J, WINDUS D, DELMEZ J: Long term effects of calcium carbonate and 2.5 mEq/L calcium dialysate on mineral metabolism. Kidney Int 36:897-903, 1989
-
(1989)
Kidney Int
, vol.36
, pp. 897-903
-
-
Slatopolsky, E.1
Weerts, C.2
Norwood, K.3
Giles, K.4
Fryer, P.5
Finch, J.6
Windus, D.7
Delmez, J.8
-
12
-
-
0024453822
-
Calcium acetate, an effective phosphorus binder in patients with renal failure
-
MAI ML, EMMETT M, SHEIKH MS, SANTA ANA CA, SCHILLER L, FORDTRAN JS: Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 36:690-695, 1989
-
(1989)
Kidney Int
, vol.36
, pp. 690-695
-
-
Mai, M.L.1
Emmett, M.2
Sheikh, M.S.3
Santa Ana, C.A.4
Schiller, L.5
Fordtran, J.S.6
-
13
-
-
0024501071
-
Reduction of dietary phosphorus absorption by phosphorus binders: A theoretical in vitro and in vivo study
-
SHEIKH MS, MAGUIRE JA, EMMETT M, SANTA ANA CA, NICAR MJ, SCHILLER LR, FORDTRAN JS: Reduction of dietary phosphorus absorption by phosphorus binders: A theoretical in vitro and in vivo study. J Clin Invest 83:66-73, 1989
-
(1989)
J Clin Invest
, vol.83
, pp. 66-73
-
-
Sheikh, M.S.1
Maguire, J.A.2
Emmett, M.3
Santa Ana, C.A.4
Nicar, M.J.5
Schiller, L.R.6
Fordtran, J.S.7
-
14
-
-
0025865170
-
The treatment of uraemic hyperphosphataemia with calcium acetate and calcium carbonate: A comparative study
-
SCHAEFER K, SCHEER J, ASMUS G, UMLAUF E, HAGEMANN J, VON HERRATH D: The treatment of uraemic hyperphosphataemia with calcium acetate and calcium carbonate: A comparative study. Nephrol Dial Transplant 6:170-175, 1991
-
(1991)
Nephrol Dial Transplant
, vol.6
, pp. 170-175
-
-
Schaefer, K.1
Scheer, J.2
Asmus, G.3
Umlauf, E.4
Hagemann, J.5
Von Herrath, D.6
-
15
-
-
0026544401
-
Control of predialytic hyperphosphatemia by oral calcium acetate and Calcium carbonate
-
MOKINIERE P, DJERAD M, BOUDAILLIEZ B, EL ESPER N, BOITTE F, WESTEEL PF, COMPAGNON M, BRAZIER M, ACHARD JM, FOURNIER A: Control of predialytic hyperphosphatemia by oral calcium acetate and Calcium carbonate. Nephron 60:6-11, 1992
-
(1992)
Nephron
, vol.60
, pp. 6-11
-
-
Mokiniere, P.1
Djerad, M.2
Boudailliez, B.3
El Esper, N.4
Boitte, F.5
Westeel, P.F.6
Compagnon, M.7
Brazier, M.8
Achard, J.M.9
Fournier, A.10
-
16
-
-
0026888709
-
Calcium acetate as a phosphorus binder in hemodialysis patients
-
DELMEZ JA, TINDIRA CA, WINDUS DW, NORWOOD KY, GILES KS, NIGHSWANDER TL, SLATOPOLSKY E: Calcium acetate as a phosphorus binder in hemodialysis patients. J Am Soc Nephrol 3:96-102, 1992
-
(1992)
J Am Soc Nephrol
, vol.3
, pp. 96-102
-
-
Delmez, J.A.1
Tindira, C.A.2
Windus, D.W.3
Norwood, K.Y.4
Giles, K.S.5
Nighswander, T.L.6
Slatopolsky, E.7
-
17
-
-
0025861521
-
Intestinal absorption of magnesium from food and supplements
-
FINE KD, SANTA ANA CA, PORTER JL, FORDTRAN JS: Intestinal absorption of magnesium from food and supplements. J Clin Invest 88:396-402, 1991
-
(1991)
J Clin Invest
, vol.88
, pp. 396-402
-
-
Fine, K.D.1
Santa Ana, C.A.2
Porter, J.L.3
Fordtran, J.S.4
-
18
-
-
0028101972
-
Acute effects of different concentrations of dialysate magnesium during high-efficiency dialysis
-
KELBER J, SLATOPOLSKY E, DELMEZ J: Acute effects of different concentrations of dialysate magnesium during high-efficiency dialysis, Am J Kidney Dis 24:453-460, 1994
-
(1994)
Am J Kidney Dis
, vol.24
, pp. 453-460
-
-
Kelber, J.1
Slatopolsky, E.2
Delmez, J.3
-
19
-
-
0003941372
-
-
Washington, D.C., Agricultural Research Service, United States Department of Agriculture, Handbook No. 456
-
ADAMS CF: Nutrititive Value of American Foods in Common Units. Washington, D.C., Agricultural Research Service, United States Department of Agriculture, 1975, Handbook No. 456
-
(1975)
Nutrititive Value of American Foods in Common Units
-
-
Adams, C.F.1
-
20
-
-
0016790435
-
Metabolism of immunoreactive parathyroid hormone in the dog: The role of the kidney and the effects of chronic renal disease
-
HRUSKA KA, KOPELMAN R, RUTHERFORD WE, KLAHR S, SLATOPOLSKY E: Metabolism of immunoreactive parathyroid hormone in the dog: The role of the kidney and the effects of chronic renal disease. J Clin Invest 56:39-48, 1975
-
(1975)
J Clin Invest
, vol.56
, pp. 39-48
-
-
Hruska, K.A.1
Kopelman, R.2
Rutherford, W.E.3
Klahr, S.4
Slatopolsky, E.5
-
21
-
-
0020058650
-
The use of magnesium-containing phosphate hinders in patients with end-stage renal disease on maintenance hemodialysis
-
GUILLOT AP, HOOD VL, RUNGE CF, GENNARI FJ: The use of magnesium-containing phosphate hinders in patients with end-stage renal disease on maintenance hemodialysis. Nephron 30:114-117, 1982
-
(1982)
Nephron
, vol.30
, pp. 114-117
-
-
Guillot, A.P.1
Hood, V.L.2
Runge, C.F.3
Gennari, F.J.4
-
22
-
-
0023270193
-
Control of hyperphosphatemia in dialysis patients: Comparison of aluminum hydroxide, calcium carbonate, and magnesium trilisate
-
MACTIER RA, LEUNG ACT, HENDERSON IS, DOBBIE JW: Control of hyperphosphatemia in dialysis patients: Comparison of aluminum hydroxide, calcium carbonate, and magnesium trilisate. Dial Transplant 16:599-601, 1987
-
(1987)
Dial Transplant
, vol.16
, pp. 599-601
-
-
Mactier, R.A.1
Leung, A.C.T.2
Henderson, I.S.3
Dobbie, J.W.4
-
23
-
-
0023639609
-
Long-term use of magnesium hydroxide as a phosphate binder in patients on hemodialysis
-
OE PL, LIPS P, VAN DER MEULEN J, DE VRIES PMJM, VAN BRONSWIJK H: Long-term use of magnesium hydroxide as a phosphate binder in patients on hemodialysis. Clin Nephrol 28:180-185, 1987
-
(1987)
Clin Nephrol
, vol.28
, pp. 180-185
-
-
Oe, P.L.1
Lips, P.2
Van Der Meulen, J.3
De Vries, P.M.J.M.4
Van Bronswijk, H.5
-
24
-
-
0022601859
-
Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia
-
O'DONOVAN R, BALDWIN D, HAMMER M, MONIZ C, PARSONS V: Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia. Lancet 1:880-882, 1986
-
(1986)
Lancet
, vol.1
, pp. 880-882
-
-
O'Donovan, R.1
Baldwin, D.2
Hammer, M.3
Moniz, C.4
Parsons, V.5
-
25
-
-
0024230581
-
Magnesium hydroxide as a complementary aluminum-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis
-
MORINIERI: P, VINATIER I, WESTEEL PF: Magnesium hydroxide as a complementary aluminum-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis. Nephrol Dial Transplant 3:651-656, 1988
-
(1988)
Nephrol Dial Transplant
, vol.3
, pp. 651-656
-
-
Morinieri, P.1
Vinatier, I.2
Westeel, P.F.3
-
26
-
-
0026515749
-
2 as sole phosphate binder
-
2 as sole phosphate binder. Nephron 60:154-163, 1992
-
(1992)
Nephron
, vol.60
, pp. 154-163
-
-
Morniere, P.1
Maurouaud, C.2
Boudailliez, B.3
Westeel, P.4
Achard, J.5
Boitte, F.6
El Esper, N.7
Compagnon, M.8
Maurel, G.9
Bouillon, R.10
Pamphile, R.11
Fournier, A.12
-
27
-
-
0014462750
-
The effect of some inhibitors on the nucleation and crystal growth of apatite
-
BACHRA BN, FISCHER HRA: The effect of some inhibitors on the nucleation and crystal growth of apatite. Calcif Tissue Res 3:269-279, 1969
-
(1969)
Calcif Tissue Res
, vol.3
, pp. 269-279
-
-
Bachra, B.N.1
Fischer, H.R.A.2
-
28
-
-
0019207541
-
Effect of magnesium on lipid-induced calcification: An in vitro model of bone mineralization
-
BOSKEY AL, POSHNER AS: Effect of magnesium on lipid-induced calcification: An in vitro model of bone mineralization. Calcif Tissue Int 32:139-143, 1980
-
(1980)
Calcif Tissue Int
, vol.32
, pp. 139-143
-
-
Boskey, A.L.1
Poshner, A.S.2
-
29
-
-
0023813295
-
Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients
-
GONELLA M, BALLANTI P, ROCCA CD, CALABRESE G, PRATESI G, VAGELLI G, MAZZOTTA A, BONUCCI E: Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients. Miner Electrol Metab 14:240-245, 1988
-
(1988)
Miner Electrol Metab
, vol.14
, pp. 240-245
-
-
Gonella, M.1
Ballanti, P.2
Rocca, C.D.3
Calabrese, G.4
Pratesi, G.5
Vagelli, G.6
Mazzotta, A.7
Bonucci, E.8
-
30
-
-
0023253389
-
Serum magnesium level and arterial calcification in end-stage renal disease
-
MEEMA HE, OREOPOULOS DG, RAPOPORT A: Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 32:388-394, 1987
-
(1987)
Kidney Int
, vol.32
, pp. 388-394
-
-
Meema, H.E.1
Oreopoulos, D.G.2
Rapoport, A.3
|